Open Angle Glaucoma Clinical Trial
Official title:
The Effect of Trabeculectomy, Glaucoma Drainage Device, Cyclophotocoagulation, and Ocular Hypotensive Eye-drops on Intraocular Pressure Fluctuation With Postural Change in Eyes With Open-angle Glaucoma
The purpose of this study is to investigate the effect of trabeculectomy, glaucoma drainage
devices, cyclophotocoagulation and ocular hypotensive eye-drops on IOP elevation with
postural change from the sitting to supine positions in eyes with open-angle glaucoma.
Patients will be assigned to the different study groups according to their past ocular
history. Interventions are similar to all study group and no medical therapy alteration will
be made.
Visual impairment and blindness due to chronic progressive optic neuropathy developing from
glaucoma are major health problems worldwide.
Glaucoma is a progressive, potentially blinding disease, in which the only modifiable risk
factor in intraocular pressure. In a significant proportion of patients, the disease
progresses despite apparent IOP control(1-3).
One factor which may explain some of this discrepancy is a fluctuation of the IOP during the
day, which may be missed in a single visit to the ophthalmologist(4). Although this
fluctuation depends to some degree on daily biologic rhythms and the specific type of
glaucoma, a constant significant factor responsible for this effect is the IOP-dependent
changes of body posture, from sitting or standing to lying down(5). Older studies have shown
IOP postural changes in the range of 4-6 mmHg(6-8). Seeing how a typical patient may spend
as much as a third of his life in the supine position, knowledge of IOP in this position,
and its control, are of great importance in decreasing the chance for irreversible optic
nerve damage.
Several studies of Liu JH(9-11) have investigated the effect of hypotensive drops on
nocturnal IOP. While prostaglandin analogues (PGA) and carbonic anhydrase inhibitors (CAI)
seemed to have a significant nocturnal IOP lowering effect, the effect seen with beta
blockers and alpha agonists was minimal. Mansouri et al.(12) recently showed that PGA seem
to flatten the IOP-related increase when moving from the sitting to the supine position at
nocturnal period, without effecting other circadian IOP-related patterns.
Hirooka Kazuyuki investigated the effect of trabeculectomy on the IOP fluctuations caused by
postural changes(13-14). He showed that successful trabeculectomy, which didn't require
needling, have significantly decreased the posture-induced IOP changes to less than 3 mmHg.
To the best of our knowledge there is no data regarding the effect of glaucoma drainage
devices and cyclophotocoagulation on supine IOP.
The purpose of this study is to investigate the effect of different IOP lowering methods,
including trabeculectomy, glaucoma drainage devices, cyclophotocoagulation and ocular
hypotensive eye-drops on IOP with postural change from the sitting to supine positions in
eyes with open-angle glaucoma.
;
Observational Model: Case Control, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03284853 -
Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension
|
Phase 3 | |
Terminated |
NCT03611530 -
CoQun Study - (COQUN): a Study to Evaluate the Effects of CoQun in Patients Affected by Open-angle Glaucoma
|
N/A | |
Not yet recruiting |
NCT06441643 -
Next Generation Rocklatan
|
Phase 2 | |
Completed |
NCT02272569 -
STARflo European Safety and Efficacy Study
|
N/A | |
Completed |
NCT02628223 -
180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma
|
N/A | |
Completed |
NCT01936389 -
A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
|
Phase 2 | |
Completed |
NCT00941525 -
Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure
|
Phase 4 | |
Completed |
NCT00539526 -
Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues
|
Phase 4 | |
Completed |
NCT00121147 -
Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan
|
N/A | |
Active, not recruiting |
NCT05035394 -
Swedish Microinvasive Glaucoma Surgery Study (SMIGS)
|
N/A | |
Completed |
NCT03450629 -
Evaluation of Safety and Efficacy of PDP-716
|
Phase 3 | |
Active, not recruiting |
NCT06061718 -
Travoprost Intraocular Implant in Conjunction With Cataract Surgery
|
Phase 3 | |
Recruiting |
NCT05241938 -
PSLT Compared to Prostaglandin Analogue Eye Drops
|
N/A | |
Completed |
NCT01342406 -
Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics
|
||
Completed |
NCT02250612 -
SYL040012, Treatment for Open Angle Glaucoma
|
Phase 2 | |
Completed |
NCT01937312 -
Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue
|
Phase 4 | |
Terminated |
NCT01983579 -
TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) Injection
|
Phase 4 | |
Completed |
NCT01937299 -
Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®
|
Phase 4 | |
Completed |
NCT01229982 -
A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
|
Phase 2 | |
Recruiting |
NCT00440336 -
Comparison of Efficacy of Two Groups of Glaucoma Drops (Xalatan vs.Cosopt) in Reducing Eye Pressure Following Laser (SLT)Treatment in the Management of Glaucoma.
|
N/A |